Nothing Special   »   [go: up one dir, main page]

DK0488513T3 - Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen - Google Patents

Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen

Info

Publication number
DK0488513T3
DK0488513T3 DK91309685.5T DK91309685T DK0488513T3 DK 0488513 T3 DK0488513 T3 DK 0488513T3 DK 91309685 T DK91309685 T DK 91309685T DK 0488513 T3 DK0488513 T3 DK 0488513T3
Authority
DK
Denmark
Prior art keywords
dioxabicyclo
drug
prepare
cholesterol metabolism
inhibiting cholesterol
Prior art date
Application number
DK91309685.5T
Other languages
Danish (da)
English (en)
Inventor
Kengo Akimoto
Sumio Asami
Michihiro Sugano
Nobuaki Hirose
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17644733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0488513(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DK0488513T3 publication Critical patent/DK0488513T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91309685.5T 1990-10-22 1991-10-21 Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen DK0488513T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28183990A JP3183664B2 (ja) 1990-10-22 1990-10-22 コレステロール及び胆汁酸の代謝阻害剤

Publications (1)

Publication Number Publication Date
DK0488513T3 true DK0488513T3 (da) 1996-06-17

Family

ID=17644733

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91309685.5T DK0488513T3 (da) 1990-10-22 1991-10-21 Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen

Country Status (9)

Country Link
US (1) US5270335A (ja)
EP (1) EP0488513B1 (ja)
JP (1) JP3183664B2 (ja)
AT (1) ATE138571T1 (ja)
CA (1) CA2053820C (ja)
DE (1) DE69119875T2 (ja)
DK (1) DK0488513T3 (ja)
ES (1) ES2087252T3 (ja)
GR (1) GR3020682T3 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06227977A (ja) * 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
AU1928295A (en) * 1994-02-25 1995-09-11 New England Deaconess Hospital Corporation Anti-inflammatory and infection protective effects of sesamin-based lignans
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
WO1997001968A1 (en) * 1995-07-04 1997-01-23 Suntory Limited FOOD COMPOSITION CONTAINING BALANCING AGENT FOR φ-6 AND φ-3 UNSATURATED FATTY ACIDS
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
KR100352269B1 (ko) * 1999-10-08 2002-09-12 한국생명공학연구원 저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
US7081260B2 (en) * 2002-10-29 2006-07-25 Council Of Scientific And Industrial Research α-Glucosidase inhibitors from a natural source
EP1864659B1 (en) 2005-03-31 2011-11-23 Suntory Holdings Limited Lignane compound-containing oil-in-water emulsion and composition comprising the same
AU2006295843B2 (en) 2005-09-30 2012-04-12 Suntory Holdings Limited A process and an apparatus for producing episesamin-rich compositions
SG10201601998PA (en) 2006-03-31 2016-04-28 Suntory Holdings Ltd Jp Compositions containing lignan-class compounds
CN101511356A (zh) 2006-10-04 2009-08-19 三得利株式会社 含有木脂素类化合物的o/w/o型乳液及含有该乳液的组合物
JP5051878B2 (ja) * 2007-03-02 2012-10-17 竹本油脂株式会社 高濃度セサミノール含有物の製造方法
AU2008301699B2 (en) 2007-09-19 2014-10-02 Suntory Holdings Limited Composition Comprising Sesamin Component and Vitamin B1 Component
WO2020174669A1 (ja) * 2019-02-28 2020-09-03 株式会社えがお 体重増加抑制・低減用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01104062A (ja) * 1987-10-16 1989-04-21 Taisho Pharmaceut Co Ltd テトラヒドロフラン誘導体
DK0409654T3 (da) * 1989-07-21 2001-12-27 Suntory Ltd Leverfunktionsforbedrende middel

Also Published As

Publication number Publication date
EP0488513B1 (en) 1996-05-29
ES2087252T3 (es) 1996-07-16
DE69119875T2 (de) 1996-10-02
JPH04159221A (ja) 1992-06-02
EP0488513A3 (en) 1992-06-17
GR3020682T3 (en) 1996-10-31
DE69119875D1 (de) 1996-07-04
EP0488513A2 (en) 1992-06-03
ATE138571T1 (de) 1996-06-15
CA2053820A1 (en) 1992-04-23
CA2053820C (en) 1997-02-04
JP3183664B2 (ja) 2001-07-09
US5270335A (en) 1993-12-14

Similar Documents

Publication Publication Date Title
DK0488513T3 (da) Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FI880510A0 (fi) Menetelmä lääkeaineena käyttökelpoisen tiatsolidinonin johdannaisen valmistamiseksi
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
AU6128590A (en) Novel compounds
AU6129890A (en) Novel compounds
ATE192038T1 (de) Arzneizusammensetzung auf basis von dioxabicyclo(3.3.0)octanderivaten
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
ES2064461T3 (es) Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
BR1101136A (pt) Derivado da pristinamicina iib, (dietilamino-2 metil-1 etil) sulfinil-26 pristinamicina iib, (dietilamino-2 propil) sulfonil-26 pristinamicina iib, (diisopropilamino-2 etil) sulfonil-26 pristinamicina iib, processo de preparação de novo derivado da pristinamicina iib e composição farmacêutica
KR860008973A (ko) 2-피롤리돈 유도체
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
HK1005015A1 (en) Osteogenesis promotion with use of vitamin d derivatives
HU907224D0 (en) Process for producing heterocyclic compounds
MX15697A (es) Derivados heterotetraciclicos de lactama y procesopara su preparacion
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
AU624724B2 (en) Pyrrolo(2,1-b)thiazole derivatives
DK480389A (da) Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet